Exercise or conversion by Thomas Englese of 937 shares of Aziyo BiologicsInc subject to Rule 16b-3

AZYODelisted Stock  USD 2.44  0.00  0.00%   
About 56% of Aziyo Biologics' investor base is looking to short. The analysis of current outlook of investing in Aziyo Biologics suggests that many traders are alarmed regarding Aziyo Biologics' prospects. Aziyo Biologics' investing sentiment overview a quick insight into current market opportunities from investing in Aziyo Biologics. Many technical investors use Aziyo Biologics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Aziyo Biologics Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Read at macroaxis.com
Aziyo insider trading alert for exercise of class a common stock by Thomas Englese, CHIEF COMMERCIAL OFFICER, on 9th of March 2023. This event was filed by Aziyo Biologics Inc with SEC on 2023-03-09. Statement of changes in beneficial ownership - SEC Form 4

Aziyo Biologics Fundamental Analysis

We analyze Aziyo Biologics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Aziyo Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Aziyo Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Profit Margin

Profit Margin Comparative Analysis

Aziyo Biologics is currently under evaluation in profit margin category among its peers. Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Aziyo Biologics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Aziyo Biologics stock to make a market-neutral strategy. Peer analysis of Aziyo Biologics could also be used in its relative valuation, which is a method of valuing Aziyo Biologics by comparing valuation metrics with similar companies.

Peers

Aziyo Biologics Related Equities

ESTAEstablishment Labs   5.73   
0%
100.0%
CVRXCVRx   4.58   
0%
79.0%
AVNSAvanos Medical   4.14   
0%
72.0%
NXLNexalin Technology   2.09   
0%
36.0%
ELMDElectromed   1.58   
0%
27.0%
ANIKAnika Therapeutics   1.36   
0%
23.0%
AXGNAxogen   0.97   
0%
16.0%
OFIXOrthofix Medical   0.69   
0%
12.0%
SRDXSurModics   0.58   
0%
10.0%
AORTArtivion   0.50   
0%
8.0%
LNSRLENSAR   0.27   
4.0%
0%
NVNOEnVVeno Medical   0.29   
5.0%
0%
SGHTSight Sciences   0.75   
13.0%
0%
IRIXIRIDEX   1.67   
29.0%
0%
SSKNSTRATA Skin   3.61   
63.0%
0%
AIMDAinos   4.26   
74.0%
0%
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.

Other Consideration for investing in Aziyo Stock

If you are still planning to invest in Aziyo Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Aziyo Biologics' history and understand the potential risks before investing.
Commodity Directory
Find actively traded commodities issued by global exchanges
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Equity Valuation
Check real value of public entities based on technical and fundamental data
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Content Syndication
Quickly integrate customizable finance content to your own investment portal